{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:39:01Z","timestamp":1789000741369,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.urolonc.2022.04.008","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T17:19:13Z","timestamp":1653326353000},"page":"304-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Patient reported outcomes and health related quality of life in localized prostate cancer: A review of current evidence"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-1636","authenticated-orcid":false,"given":"Eyal","family":"Kord","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Paul","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasza","family":"Posielski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"On","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2022.04.008_bib0001","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"41","key":"10.1016\/j.urolonc.2022.04.008_bib0002","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","article-title":"Prostate cancer incidence and survival, by stage and race\/ethnicity - United States, 2001-2017","volume":"69","author":"Siegel","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.urolonc.2022.04.008_bib0003","first-page":"479","article-title":"Prostate cancer, Version 2.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J Nat Compr CancNetw"},{"issue":"15","key":"10.1016\/j.urolonc.2022.04.008_bib0004","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.urolonc.2022.04.008_bib0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","article-title":"Radical prostatectomy versus observation for localized prostate cancer","volume":"367","author":"Wilt","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.urolonc.2022.04.008_bib0006","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.eururo.2015.04.023","article-title":"Survivorship and improving quality of life in men with prostate cancer","volume":"68","author":"Bourke","year":"2015","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.urolonc.2022.04.008_bib0007","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jama.2017.1704","article-title":"Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years","volume":"317","author":"Barocas","year":"2017","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.urolonc.2022.04.008_bib0008","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jama.2017.1652","article-title":"Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer","volume":"317","author":"Chen","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.urolonc.2022.04.008_bib0009","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.2019.20675","article-title":"Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer","volume":"323","author":"Hoffman","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.urolonc.2022.04.008_bib0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer","volume":"368","author":"Resnick","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.urolonc.2022.04.008_bib0011","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1023\/A:1008931703884","article-title":"Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings","volume":"9","author":"Giesler","year":"2000","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.urolonc.2022.04.008_bib0012","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/00005650-199807000-00007","article-title":"The UCLA prostate cancer index: development, reliability, and validity of a health-related quality of life measure","volume":"36","author":"Litwin","year":"1998","journal-title":"Med Care"},{"issue":"8","key":"10.1016\/j.urolonc.2022.04.008_bib0013","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s11136-014-0678-8","article-title":"Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments","volume":"23","author":"Schmidt","year":"2014","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.urolonc.2022.04.008_bib0014","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.urolonc.2022.04.008_bib0015","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0959-8049(99)00193-8","article-title":"Quality of life instruments in oncology","volume":"35","author":"Velikova","year":"1999","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"issue":"6","key":"10.1016\/j.urolonc.2022.04.008_bib0016","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0090-4295(97)00459-7","article-title":"Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument","volume":"50","author":"Esper","year":"1997","journal-title":"Urology"},{"issue":"16","key":"10.1016\/j.urolonc.2022.04.008_bib0017","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.ejca.2008.07.030","article-title":"An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer","volume":"44","author":"van Andel","year":"2008","journal-title":"Eur Jo Cancer (Oxford, England : 1990)"},{"issue":"5","key":"10.1016\/j.urolonc.2022.04.008_bib0018","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","article-title":"Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors","volume":"76","author":"Szymanski","year":"2010","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.urolonc.2022.04.008_bib0019","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bju.13896","article-title":"Patient-reported outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments","volume":"120","author":"Protopapa","year":"2017","journal-title":"BJU Int"},{"issue":"16","key":"10.1016\/j.urolonc.2022.04.008_bib0020","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/jnci\/djn255","article-title":"Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial","volume":"100","author":"Bill-Axelson","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.urolonc.2022.04.008_bib0021","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1470-2045(11)70162-0","article-title":"Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial","volume":"12","author":"Johansson","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2022.04.008_bib0022","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of prostatectomy versus observation for early prostate cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.urolonc.2022.04.008_bib0023","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.urolonc.2022.04.008_bib0024","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: An analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.urolonc.2022.04.008_bib0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bju.14215","article-title":"Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting)","volume":"122","author":"Ansmann","year":"2018","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.urolonc.2022.04.008_bib0026","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.eururo.2017.08.013","article-title":"Long-term psychological and quality-of-life effects of active surveillance and watchful waiting after diagnosis of low-risk localised prostate cancer","volume":"73","author":"Egger","year":"2018","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2022.04.008_bib0027","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.radonc.2013.05.038","article-title":"Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up","volume":"108","author":"Ferrer","year":"2013","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.04.008_bib0028","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3892\/ijo.2014.2734","article-title":"Long-term health-related quality of life after curative treatment for prostate cancer: a regional cross-sectional comparison of two standard treatment modalities","volume":"46","author":"Hj\u00e4lm-Eriksson","year":"2015","journal-title":"Int J Oncol"},{"issue":"14","key":"10.1016\/j.urolonc.2022.04.008_bib0029","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/cncr.29370","article-title":"Prospective quality-of-life outcomes for low-risk prostate cancer: active surveillance versus radical prostatectomy","volume":"121","author":"Jeldres","year":"2015","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2022.04.008_bib0030","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/jrr\/rrt049","article-title":"Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer","volume":"54","author":"Shinohara","year":"2013","journal-title":"J Radiat Res (Tokyo)"},{"issue":"5","key":"10.1016\/j.urolonc.2022.04.008_bib0031","first-page":"e13076","article-title":"Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study","volume":"28","author":"Adam","year":"2019","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"6","key":"10.1016\/j.urolonc.2022.04.008_bib0032","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3109\/0284186X.2014.974827","article-title":"Radical prostatectomy versus high-dose irradiation in localized\/locally advanced prostate cancer: a Swedish multicenter randomized trial with patient-reported outcomes","volume":"54","author":"Lennern\u00e4s","year":"2015","journal-title":"Acta oncologica (Stockholm, Sweden)"},{"issue":"2","key":"10.1016\/j.urolonc.2022.04.008_bib0033","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.urology.2014.09.046","article-title":"Patient-perceived satisfaction after definitive treatment for men with high-risk prostate cancer: radical prostatectomy vs. intensity-modulated radiotherapy with androgen deprivation therapy","volume":"85","author":"Yamamoto","year":"2015","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.urolonc.2022.04.008_bib0034","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/cncr.33388","article-title":"Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer","volume":"127","author":"Pasalic","year":"2021","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2022.04.008_bib0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1200\/JCO.2010.31.7305","article-title":"Comparison of health-related quality of life 5 years after SPIRIT: surgical prostatectomy versus interstitial radiation intervention trial","volume":"29","author":"Crook","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2022.04.008_bib0036","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijrobp.2017.02.019","article-title":"External beam radiation therapy or brachytherapy with or without short-course neoadjuvant androgen deprivation therapy: results of a multicenter, prospective study of quality of life","volume":"98","author":"Gay","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.urolonc.2022.04.008_bib0037","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.prro.2014.10.003","article-title":"The impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer","volume":"5","author":"Son","year":"2015","journal-title":"Pract Radiat Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2022.04.008_bib0038","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1464-410X.2011.10846.x","article-title":"Sexual function with localized prostate cancer: active surveillance vs radical therapy","volume":"110","author":"van den Bergh","year":"2012","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2022.04.008_bib0039","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.juro.2016.02.2972","article-title":"Prospective quality of life in men choosing active surveillance compared to those biopsied but not diagnosed with prostate cancer","volume":"196","author":"Pham","year":"2016","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2022.04.008_bib0040","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1002\/cam4.3018","article-title":"Harnessing the patient voice in prostate cancer research: systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making","volume":"9","author":"Van Hemelrijck","year":"2020","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.urolonc.2022.04.008_bib0041","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.urolonc.2022.04.008_bib0042","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.apmr.2007.08.110","article-title":"Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy","volume":"88","author":"Monga","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.urolonc.2022.04.008_bib0043","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2147\/CIA.S228222","article-title":"The impact of pelvic floor muscle training on urinary incontinence in men after radical prostatectomy (RP) - a systematic review","volume":"14","author":"Str\u0105czy\u0144ska","year":"2019","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.urolonc.2022.04.008_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2021.101913","article-title":"Effect of Kegel exercises on the prevention of urinary and fecal incontinence in patients with prostate cancer undergoing radiotherapy","volume":"51","author":"Urvayl\u0131o\u011flu","year":"2021","journal-title":"Eur J Oncol Nurs"},{"issue":"4","key":"10.1016\/j.urolonc.2022.04.008_bib0045","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/cncr.21231","article-title":"Improving the quality of life of patients with prostate carcinoma: a randomized trial testing the efficacy of a nurse-driven intervention","volume":"104","author":"Giesler","year":"2005","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2022.04.008_bib0046","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bju.12253","article-title":"Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo","volume":"112","author":"Pavlovich","year":"2013","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.urolonc.2022.04.008_bib0047","article-title":"Surgical treatment for urinary incontinence after prostatectomy: a meta-analysis and systematic review","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.urolonc.2022.04.008_bib0048","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S1470-2045(18)30357-7","article-title":"Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study","volume":"19","author":"Coughlin","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.04.008_bib0049","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ucl.2020.09.012","article-title":"Retzius-sparing robot-assisted robotic prostatectomy: past, present, and future","volume":"48","author":"Davis","year":"2021","journal-title":"Urol Clin North Am"},{"issue":"2","key":"10.1016\/j.urolonc.2022.04.008_bib0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.radonc.2015.07.016","article-title":"Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy","volume":"116","author":"Evans","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2022.04.008_bib0051","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.eururo.2019.02.026","article-title":"Patient-reported quality of life following stereotactic body radiotherapy and conventionally fractionated external beam radiotherapy compared with active surveillance among men with localized prostate cancer","volume":"76","author":"Moon","year":"2019","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2022.04.008_bib0052","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11912-017-0584-7","article-title":"The role of hypofractionated radiotherapy in prostate cancer","volume":"19","author":"Benjamin","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.urolonc.2022.04.008_bib0053","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/j.urology.2021.05.013","article-title":"SpaceOAR Hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. A systematic review","volume":"156","author":"Armstrong","year":"2021","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.urolonc.2022.04.008_bib0054","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.urolonc.2016.12.015","article-title":"A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy","volume":"35","author":"Banerji","year":"2017","journal-title":"Urol Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392200117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392200117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:25:52Z","timestamp":1761042352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814392200117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S107814392200117X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.04.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient reported outcomes and health related quality of life in localized prostate cancer: A review of current evidence","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}